Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
New England Journal of Medicine (2017) - Comments
pubmed: 28199814  doi: 10.1056/nejmoa1608345  issn: 1533-4406  issn: 0028-4793 

Peter C. Taylor, Edward C. Keystone, Désirée Van Der Heijde, Michael E. Weinblatt, Liliana Del Carmen Morales, Jaime Reyes Gonzaga, Sergey Yakushin, Taeko Ishii, Kahaku Emoto, Scott Beattie, Vipin Arora, Carol Gaich, Terence Rooney, Douglas Schlichting, William L. Macias, Stephanie De Bono, Yoshiya Tanaka